tiprankstipranks
Advertisement
Advertisement
Goldman Sachs Discloses 3.15% Stake in Qiagen via AFM Filing
PremiumCompany AnnouncementsGoldman Sachs Discloses 3.15% Stake in Qiagen via AFM Filing
5d ago
T. Rowe Price Discloses 5.12% Stake in Qiagen
Premium
Company Announcements
T. Rowe Price Discloses 5.12% Stake in Qiagen
10d ago
Bank of America Reports 4.69% Stake in Qiagen
Premium
Company Announcements
Bank of America Reports 4.69% Stake in Qiagen
10d ago
Vanguard Discloses 3.17% Direct Stake in QIAGEN
PremiumCompany AnnouncementsVanguard Discloses 3.17% Direct Stake in QIAGEN
10d ago
10x Genomics reports patent infringement win against Parse Biosciences
Premium
The Fly
10x Genomics reports patent infringement win against Parse Biosciences
10d ago
Qiagen announces commercial launch of QIAsymphony Connect
Premium
The Fly
Qiagen announces commercial launch of QIAsymphony Connect
11d ago
Qiagen: CEO Appointment and Strategic Review Temper Takeover Hopes, Justifying Hold Rating on Valuation
PremiumRatingsQiagen: CEO Appointment and Strategic Review Temper Takeover Hopes, Justifying Hold Rating on Valuation
14d ago
Qiagen trading resumes
Premium
The Fly
Qiagen trading resumes
14d ago
Qiagen appoints Jonathan Pratt as CEO, effective Sept. 1
Premium
The Fly
Qiagen appoints Jonathan Pratt as CEO, effective Sept. 1
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100